G1 Therapeutics, Inc. ( GTHX) - Key Metrics
Stock symbol GTHX is outdated, potentially delisted? Maybe it is available on other exchange?
GTHX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.32 | -$0.10 | -$0.10 | -$0.10 |
| 2024Q1 | $0.28 | -$0.20 | -$0.17 | -$0.17 |
| 2023Q4 | $0.29 | -$0.21 | -$0.25 | -$0.25 |
| 2023Q3 | $0.24 | -$0.35 | -$0.20 | -$0.20 |
| 2023Q2 | $0.82 | $0.17 | $0.27 | $0.27 |
GTHX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -5.92 |
| 2024Q1 | ? | -5.81 |
| 2023Q4 | ? | -3.63 |
| 2023Q3 | ? | -1.02 |
| 2023Q2 | ? | 3.69 |
GTHX
Price: $7.16
52 week price:
Earnings Per Share: -0.86 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 586179
Ebitda: -15.9 millionMarket Capitalization: 377.2 million